Amyloid Neuropathies, Familial
"Amyloid Neuropathies, Familial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.
| Descriptor ID |
D028227
|
| MeSH Number(s) |
C10.574.500.050 C10.668.829.050.050 C16.320.400.050 C16.320.565.176.050 C18.452.648.176.050 C18.452.845.500.050.050 C18.452.845.500.075.050
|
| Concept/Terms |
Amyloid Neuropathies, Familial- Amyloid Neuropathies, Familial
- Amyloid Neuropathy, Familial
- Familial Amyloid Neuropathies
- Familial Amyloid Neuropathy
- Neuropathies, Familial Amyloid
- Neuropathy, Familial Amyloid
- Hereditary Neuropathic Amyloidosis
- Amyloidoses, Hereditary Neuropathic
- Amyloidosis, Hereditary Neuropathic
- Hereditary Neuropathic Amyloidoses
- Neuropathic Amyloidoses, Hereditary
- Neuropathic Amyloidosis, Hereditary
- Familial Amyloid Polyneuropathies
- Amyloid Polyneuropathies, Familial
- Amyloid Polyneuropathy, Familial
- Familial Amyloid Polyneuropathy
- Polyneuropathies, Familial Amyloid
- Polyneuropathy, Familial Amyloid
Amyloid Polyneuropathy, British Type- Amyloid Polyneuropathy, British Type
- Type III Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type III
- Iowa Type Amyloid Polyneuropathy
- Amyloid Polyneuropathy, Iowa Type
- British Type Amyloid Polyneuropathy
Familial Amyloid Neuropathy, Portuguese Type- Familial Amyloid Neuropathy, Portuguese Type
- Familial Amyloid Neuropathy, Andrade Type
- Familial Amyloid Polyneuropathy, Type I
- Familial Portuguese Polyneuritic Amyloidosis
- Wohlwill-Corino Andrade Syndrome
- Syndrome, Wohlwill-Corino Andrade
- Wohlwill Corino Andrade Syndrome
- Polyneuritic Amyloidosis, Portuguese
- Amyloidoses, Portuguese Polyneuritic
- Amyloidosis, Portuguese Polyneuritic
- Polyneuritic Amyloidoses, Portuguese
- Portuguese Polyneuritic Amyloidoses
- Portuguese Polyneuritic Amyloidosis
- Portuguese Type Familial Amyloid Neuropathy
- Type I Familial Amyloid Polyneuropathy
- Wohlwill-Andrade Syndrome
- Syndrome, Wohlwill-Andrade
- Wohlwill Andrade Syndrome
- Amyloid Neuropathy Type 1
- Neuropathic Amyloid Syndrome
- Amyloid Syndrome, Neuropathic
- Amyloid Syndromes, Neuropathic
- Neuropathic Amyloid Syndromes
- Syndrome, Neuropathic Amyloid
- Syndromes, Neuropathic Amyloid
Familial Amyloid Polyneuropathy, Type V- Familial Amyloid Polyneuropathy, Type V
- Finnish Type Familial Amyloid Neuropathy
- Type V Familial Amyloid Polyneuropathy
- Familial Amyloid Neuropathy, Finnish Type
Amyloid Polyneuropathy, Swiss Type- Amyloid Polyneuropathy, Swiss Type
- Swiss Type Amyloid Polyneuropathy
- Type II Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type II
|
Below are MeSH descriptors whose meaning is more general than "Amyloid Neuropathies, Familial".
- Diseases [C]
- Nervous System Diseases [C10]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Amyloid Neuropathies, Familial [C10.574.500.050]
- Neuromuscular Diseases [C10.668]
- Peripheral Nervous System Diseases [C10.668.829]
- Amyloid Neuropathies [C10.668.829.050]
- Amyloid Neuropathies, Familial [C10.668.829.050.050]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Amyloid Neuropathies, Familial [C16.320.400.050]
- Metabolism, Inborn Errors [C16.320.565]
- Amyloidosis, Familial [C16.320.565.176]
- Amyloid Neuropathies, Familial [C16.320.565.176.050]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Metabolism, Inborn Errors [C18.452.648]
- Amyloidosis, Familial [C18.452.648.176]
- Amyloid Neuropathies, Familial [C18.452.648.176.050]
- Proteostasis Deficiencies [C18.452.845]
- Amyloidosis [C18.452.845.500]
- Amyloid Neuropathies [C18.452.845.500.050]
- Amyloid Neuropathies, Familial [C18.452.845.500.050.050]
- Amyloidosis, Familial [C18.452.845.500.075]
- Amyloid Neuropathies, Familial [C18.452.845.500.075.050]
Below are MeSH descriptors whose meaning is more specific than "Amyloid Neuropathies, Familial".
This graph shows the total number of publications written about "Amyloid Neuropathies, Familial" by people in this website by year, and whether "Amyloid Neuropathies, Familial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloid Neuropathies, Familial" by people in Profiles.
-
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.
-
Long-Term Efficacy and Safety of Acoramidis in ATTR-CM: Initial Report From the Open-Label Extension of the ATTRibute-CM Trial. Circulation. 2025 Mar 04; 151(9):601-611.
-
Defining echocardiographic predictors of outcome in cardiac amyloidosis by subtype. Curr Probl Cardiol. 2024 Sep; 49(9):102729.
-
99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study. Muscle Nerve. 2023 Feb; 67(2):111-116.
-
Impact of Tafamidis on Survival in a Real-World Community-Based Cohort. Curr Probl Cardiol. 2022 Dec; 47(12):101358.
-
Progressive Multiple Mononeuropathy in a Patient With Familial Transthyretin Amyloidosis After Liver Transplantation. J Clin Neuromuscul Dis. 2022 Mar 01; 23(3):143-147.
-
Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study. Sci Rep. 2022 01 07; 12(1):140.
-
Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression. Orphanet J Rare Dis. 2021 10 03; 16(1):411.
-
Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis. J Am Heart Assoc. 2021 05 04; 10(9):e019840.
-
Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2021 01; 14(1):302-304.